Antibiotic consumption in Shandong Province, China: An analysis of provincial pharmaceutical centralized bidding procurement data at public healthcare institutions, 2012-16

Journal of Antimicrobial Chemotherapy

Volumn 73, Issue 3, 2018, Pages 814-820

  Yin, Jia ^a   Li, Qinwei ^b   Sun, Qiang ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Public Resources Trading Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP; ARTICLE; CHINA; DRUG USE; GENERAL HOSPITAL; HUMAN; PRIMARY HEALTH CARE; PRIVATE HOSPITAL; PUBLIC HEALTH; PUBLIC HOSPITAL; RURAL AREA; SECONDARY CARE CENTER; TERTIARY CARE CENTER; URBAN HEALTH; DRUG UTILIZATION; ECONOMICS; LEGISLATION AND JURISPRUDENCE; PHARMACY (SHOP); RURAL POPULATION; STATISTICS AND NUMERICAL DATA; TRENDS;

ANTI-BACTERIAL AGENTS; CHINA; DRUG UTILIZATION; HUMANS; PHARMACY; PRIMARY HEALTH CARE; PUBLIC HEALTH; RURAL POPULATION; TERTIARY CARE CENTERS;

EID: 85043351385     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx469     Document Type: Article

References (36)

1. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
2. Hsu LY, Tan TY, Tam VH et al. Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 2010; 54: 1173-8.
3. WHO. WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva, Switzerland, 2001. http://apps.who.int/iris/bitstream/10665/66860/1/WHO_CDS_CSR_DRS_2001.2.pdf?ua"1.
4. Van Boeckel TP, Gandra S, Ashok A et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014; 14: 742-50.
5. Zhao QQ, Ying GG, Pan CG et al. Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance. Environ Sci Technol 2015; 49: 6772-82.
6. Zou G, Wei X, Hicks JP et al. Protocol for a pragmatic cluster randomised controlled trial for reducing irrational antibiotic prescribing among children with upper respiratory infections in rural China. BMJ Open 2016; 6: e010544.
7. China Antimicrobial Resistance Surveilance System. National Antimicrobial Resistance Surveilance Report, 2015. Bejing, China, 2015 http://www.carss.cn/Sys/res/file/201512/20151220130134_7741_482f3b7ae95841998a37898e2ab2fa87_2015.pdf.
8. National Health and Family Planning Commission. Plan on Recent Priorities in Carrying Out the Reform of Health Care System (2009-2011). Beijing, China, 2009 http://www.gov.cn/zwgk/2009-04/07/content_1279256.htm.
9. National Health and Family Planning Commission. Further Standardize the Drug Centralized Bidding Procurement in Hospitals. Beijing, China, 2009 http://www.sda.gov.cn/WS01/CL0056/35597.html.
10. Xiao Y, Li L. Legislation of clinical antibiotic use in China. Lancet Infect Dis 2013; 13: 189-91.
11. National Health and Family Planning Commission. The Announcement of Administrative Measures for the Clinical Use of Antibiotics in 2014. Beijing, China, 2014 http://www.nhfpc.gov.cn/yzygj/s3593/201404/49973560ddde4293a489b158081d777c.shtml.
12. The State Council. Opinion on Fully Implementing the Comprehensive Reform of County-Level Public Hospitals. 2015. http://www.gov.cn/zhengce/content/2015-05/08/content_9710.html.
13. National Health and Family Planning Commission. Guideline on Antibiotic Use in Clinical Practice. Beijing, China, 2015 http://www.nhfpc.gov.cn/ewebeditor/uploadfile/2015/09/20150928170007470.pdf.
14. National Health and Family Planning Commission. Improving Administrative Measures for the Clinical Use of Antibiotics. Beijing, China, 2015 http://www.nhfpc.gov.cn/yzygj/s3593/201508/f0fdf1f52df14b87aa97be53819f1036.shtml.
15. Bao L, Peng R, Wang Y et al. Significant reduction of antibiotic consumption and patients' costs after an action plan in China, 2010-2014. PLoS One 2015; 10: e0118868.
16. Li X, Liang Z, Yin A et al. Comparative analysis of the operation status of non-public hospitals and public hospitals in Shandong Province. Med Soc 2015; 28: 35-7.
17. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2013. Oslo, Norway, 2012 https://www.whocc.no/filearchive/publications/1_2013guidelines.pdf.
18. Yoon YK, Park GC, An H et al. Trends of antibiotic consumption in Korea according to national reimbursement data (2008-2012): a population-based epidemiologic study. Medicine (Baltimore) 2015; 94: e2100.
19. Kan QC, Wen JG, Liu XH et al. Inappropriate use of antibiotics in children in China. Lancet 2016; 387: 1273-4.
20. Morgan DJ, Okeke IN, Laxminarayan R et al. Non-prescription antimicrobial useworldwide: a systematic review. Lancet Infect Dis 2011; 11: 692-701.
21. Chang J, Ye D, Lv B et al. Sale of antibioticswithout a prescription at community pharmacies in urban China: a multicentre cross-sectional survey. JAntimicrobChemother 2017; 72: 1235-42.
22. Fang Y. China should curb non-prescription use of antibiotics in the community. BMJ 2014; 348: g4233.
23. Li R, Xiao F, Zheng X et al. Antibioticmisuse among childrenwith diarrhea in China: results from a national survey. PeerJ 2016; 4: e2668.
24. Fourteen Chinese Government Ministries and Administrations. A Five-Year National Action Plan to Contain Antimicrobial Resistance (2016-2020). Bejing, China, 2016 http://www.moh.gov.cn/yzygj/s3593/201608/f1ed26a0c8774e1c8fc89dd481ec84d7.shtml.
25. Wei X, Yin J, Walley JD et al. Impact of China's essential medicines scheme and zero-mark-up policy on antibiotic prescriptions in county hospitals:a mixedmethods study. Trop Med Int Health 2017; 22: 1166-74.
26. Wang HH, Wang JJ, Wong SY et al. Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162, 464 community household residents in southern China. BMC Med 2014; 12: 188.
27. Stimac D, Vukusi_c I, Culig J. Outpatient use of systemic antibiotics in Croatia. PharmWorld Sci 2005; 27: 230-5.
28. McCarthy M. USwarns against use of fluoroquinolones for uncomplicated infections BMJ 2016; 353: i2755.
29. Reynolds L, McKee M. Factors influencing antibiotic prescribing in China:an exploratory analysis. Health Policy 2009; 90: 32-6.
30. Committee on Infectious Diseases. The use of systemic fluoroquinolones. Pediatrics 2006; 118: 1287-92.
31. Hao X, Cao Y, Zhang L et al. Fluoroquinolones in the Wenyu River catchment, China: occurrence simulation and risk assessment. Environ Toxicol Chem 2015; 34: 2764-70.
32. Andrajati R, Tilaqza A, Supardi S. Factors related to rational antibiotic prescriptions in community health centers in Depok City, Indonesia. J Infect Public Health 2017; 10: 41-8.
33. Sun Q, Dyar OJ, Zhao L et al. Overuse of antibiotics for the common cold-attitudes and behaviors among doctors in rural areas of Shandong Province, China. BMC Pharmacol Toxicol 2015; 16: 6.
34. Dyar OJ, Beović B, Vlahović-Palčevski V et al. How can we improve antibiotic prescribing in primary care? Expert Rev Anti Infect Ther 2016; 14: 403-13.
35. Meeker D, Linder JA, Fox CR et al. Effect of behavioral interventions on inappropriate antibiotic prescribingamong primary care practices: a randomized clinical trial. JAMA 2016; 315: 562-70.
36. Yang L, Liu C, Wang L et al. Public reporting improves antibiotic prescribing for upper respiratory tract infections in primary care: amatched-pair clusterrandomized trial in China. Health Res Policy Syst 2014; 12: 61.